bioRxiv Science⌕ Search

Biology subjects

Baker, M. S.

Publications and source records attributed to Baker, M. S..

3 recordsLinked to original sources

Systemic interindividual epigenetic variation in humans is associated with transposable elements and under strong genetic control

Genetic variants can modulate phenotypic outcomes via epigenetic intermediates, for example by affecting DNA methylation at CpG dinucleotides (methylation quantitative trait loci - mQTL). Here, we present the first large-scale assessment of mQTL at human genomic regions selected for interindividual variation in CpG methylation (correlated regions of systemic interindividual variation - CoRSIVs). We used target-capture bisulfite sequencing to assess DNA methylation at 4,086 CoRSIVs in multiple tissues from 188 donors in the NIH Genotype-Tissue Expression (GTEx) program (807 samples total). At CoRSIVs, as expected, DNA methylation in peripheral blood correlates with methylation and gene expression in internal organs. We also discovered unprecedented mQTL at these regions. Genetic influences on CoRSIV methylation are extremely strong (median R2=0.76), cumulatively comprising over 70-fold more human mQTL than detected in the most powerful previous study. Moreover, mQTL beta coefficients at CoRSIVs are highly skewed (i.e., the major allele predicts higher methylation). Both surprising findings were independently validated in a cohort of 47 non-GTEx individuals. Genomic regions flanking CoRSIVs show long-range enrichments for LINE-1 and LTR transposable elements; the skewed beta coefficients may therefore reflect evolutionary selection of genetic variants that promote their methylation and silencing. Analyses of GWAS summary statistics show that mQTL polymorphisms at CoRSIVs are associated with metabolic and other classes of disease. A focus on systemic interindividual epigenetic variants, clearly enhanced in mQTL content, should likewise benefit studies attempting to link human epigenetic variation to risk of disease. Our CoRSIV-capture reagents are commercially available from Agilent Technologies, Inc. Significance StatementPopulation epigeneticists have relied almost exclusively on CpG methylation arrays manufactured by Illumina. At most of the >400,000 CpG sites covered by those arrays, however, methylation does not vary appreciably between individuals. We previously identified genomic loci that exhibit systemic (i.e. not tissue-specific) interindividual variation in DNA methylation (CoRSIVs). These can be assayed in blood DNA and, unlike tissue-specific epigenetic variants, do not reflect interindividual variation in cellular composition. Here, studying just 4,086 CoRSIVs in multiple tissues of 188 individuals, we detect much stronger genetic influences on DNA methylation (mQTL) than ever before reported. Because interindividual epigenetic variation is essential for not only mQTL detection, but also for epigenetic epidemiology, our results indicate a major opportunity to advance this field.

genetics↗

A Recombinant Protein Biomarker DDA Library Increases DIA Coverage of Low Abundance Plasma Proteins

Credible detection and quantification of low abundance proteins from human blood plasma is a major challenge in precision medicine biomarker discovery when using mass spectrometry (MS). Here, we employed a mixture of recombinant proteins in DDA libraries to subsequently detect cancer-associated low abundance plasma proteins using SWATH/DIA. The exemplar DDA recombinant protein spectral library (rPSL) was derived from tryptic digestion of 36 human recombinant proteins that had been previously implicated as possible cancer biomarkers in both our own and other studies. The rPSL was then used to identify proteins from non-depleted colorectal cancer (CRC) plasmas by SWATH-MS. Most (32/36) of the proteins in the rPSL were reliably identified in plasma samples, including 8 proteins (BTC, CXCL10, IL1B, IL6, ITGB6, TGF, TNF, TP53) not previously detected using high-stringency MS in human plasmas according to PeptideAtlas. The rPSL SWATH-MS protocol was compared to DDA-MS using MARS-depleted and post-digestion peptide fractionated plasmas (here referred to as a human plasma DDA library). Of the 32 proteins identified using rPSL SWATH, only 12 were identified using DDA-MS. The 20 additional proteins exclusively identified by using the rPSL approach with SWATH were mostly lower abundance (i.e., <10ng/ml) plasma proteins. To mitigate FDR concerns, and replicating a more typical approach, the DDA rPSL was also merged into a human plasma DDA library. When SWATH identification was repeated using this merged library, the majority (33/36) of low abundance plasma proteins from the rPSL could still be identified using high-stringency HPP Guidelines v3.0 protein inference criteria.

biochemistry↗

Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 3.0

The Human Proteome Organizations (HUPO) Human Proteome Project (HPP) developed Mass Spectrometry (MS) Data Interpretation Guidelines that have been applied since 2016. These guidelines have helped ensure that the emerging draft of the complete human proteome is highly accurate and with low numbers of false-positive protein identifications. Here, we describe an update to these guidelines based on consensus-reaching discussions with the wider HPP community over the past year. The revised 3.0 guidelines address several major and minor identified gaps. We have added guidelines for emerging data independent acquisition (DIA) MS workflows and for use of the new Universal Spectrum Identifier (USI) system being developed by the HUPO Proteomics Standards Initiative (PSI). In addition, we discuss updates to the standard HPP pipeline for collecting MS evidence for all proteins in the HPP, including refinements to minimum evidence. We present a new plan for incorporating MassIVE-KB into the HPP pipeline for the next (HPP 2020) cycle in order to obtain more comprehensive coverage of public MS data sets. The main checklist has been reorganized under headings and subitems and related guidelines have been grouped. In sum, Version 2.1 of the HPP MS Data Interpretation Guidelines has served well and this timely update to version 3.0 will aid the HPP as it approaches its goal of collecting and curating MS evidence of translation and expression for all predicted [~]20,000 human proteins encoded by the human genome.\n\n\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=134 SRC=\"FIGDIR/small/733576v2_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (18K):\norg.highwire.dtl.DTLVardef@8765f2org.highwire.dtl.DTLVardef@136235aorg.highwire.dtl.DTLVardef@14aef76org.highwire.dtl.DTLVardef@af33d2_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioinformatics↗